Apotex Seeks To Maintain 156 Days Of Exclusivity For Generic Plavix
This article was originally published in The Pink Sheet Daily
Executive Summary
Apotex petitions FDA to stay action on other clopidogrel ANDAs, as Dr. Reddy’s gets into position for a generic launch.
You may also be interested in...
Generic Plavix Is Expected to Launch in Germany In Mid-August
The two companies with rights to market a generic version of Plavix (clopidogrel) in Germany are mum about their launch date. But Sanofi-Aventis, which markets Plavix with Bristol-Myers Squibb, does not expect to see generic products on the German market before mid-August
Generic Plavix Is Expected to Launch in Germany In Mid-August
The two companies with rights to market a generic version of Plavix (clopidogrel) in Germany are mum about their launch date. But Sanofi-Aventis, which markets Plavix with Bristol-Myers Squibb, does not expect to see generic products on the German market before mid-August
Plavix Patent Upheld By Court, Blocking Generic Clopidogrel
Apotex says it will immediately appeal the decision in favor of Sanofi-Aventis/Bristol-Myers Squibb.